Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19456822rdf:typepubmed:Citationlld:pubmed
pubmed-article:19456822lifeskim:mentionsumls-concept:C0019169lld:lifeskim
pubmed-article:19456822lifeskim:mentionsumls-concept:C0008115lld:lifeskim
pubmed-article:19456822lifeskim:mentionsumls-concept:C1709272lld:lifeskim
pubmed-article:19456822pubmed:issue5lld:pubmed
pubmed-article:19456822pubmed:dateCreated2010-4-16lld:pubmed
pubmed-article:19456822pubmed:abstractTextThe geographical distribution of hepatitis B virus (HBV) subgenotypes and their clinical implications in patients with acute and chronic hepatitis B in the Heilung-kiang province of northeast China were investigated. Nested PCR and multiplex PCR were performed with genotype-specific primers and with subgenotype-specific primers to identify genotypes and subgenotypes from serum samples of 412 HBV infections including 69 with acute self-limited hepatitis (ASH) and 343 with chronic hepatitis (CH). A total of 361 samples were genotyped and 304 were further subgenotyped. The most common HBV genotype was C (93.63%, 338/361), with subgenotype group C2 (83.73%, 283/338) predominating. Genotype B was also found and subgenotype B2 predominated within this genotype. Out of 69 infected patients with ASH, 48 were identified as genotype C and all belonged to subgenotype C2. Of 343 infected patients with CH, 313 were genotyped and 256 were subgenotyped; amongst these, C2 (91.80%, 235/256), B2 (7.42%, 19/256) and mixed subgenotypes B2 and C2 (0.78%, 2/256) were found. In HBV subgenotype C2 infections, ASH had a higher ratio of women than CH patients. These results show that HBV subgenotypes C2 and B2 were found in Heilung-kiang province of northeast China. In ASH and CH groups, the distributions of subgenotypes were coincident with C2, the predominant subgenotype. Analysis of the association between subgenotype and the outcomes of HBV infection was inconclusive in our study.lld:pubmed
pubmed-article:19456822pubmed:languageenglld:pubmed
pubmed-article:19456822pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19456822pubmed:citationSubsetIMlld:pubmed
pubmed-article:19456822pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19456822pubmed:statusMEDLINElld:pubmed
pubmed-article:19456822pubmed:monthMaylld:pubmed
pubmed-article:19456822pubmed:issn1469-0691lld:pubmed
pubmed-article:19456822pubmed:authorpubmed-author:LiuWWlld:pubmed
pubmed-article:19456822pubmed:authorpubmed-author:EYGGlld:pubmed
pubmed-article:19456822pubmed:authorpubmed-author:LiY PYPlld:pubmed
pubmed-article:19456822pubmed:authorpubmed-author:LUPPlld:pubmed
pubmed-article:19456822pubmed:authorpubmed-author:WangH YHYlld:pubmed
pubmed-article:19456822pubmed:authorpubmed-author:ZhangS YSYlld:pubmed
pubmed-article:19456822pubmed:authorpubmed-author:JinXXlld:pubmed
pubmed-article:19456822pubmed:authorpubmed-author:GuH XHXlld:pubmed
pubmed-article:19456822pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19456822pubmed:volume16lld:pubmed
pubmed-article:19456822pubmed:ownerNLMlld:pubmed
pubmed-article:19456822pubmed:authorsCompleteYlld:pubmed
pubmed-article:19456822pubmed:pagination477-81lld:pubmed
pubmed-article:19456822pubmed:meshHeadingpubmed-meshheading:19456822...lld:pubmed
pubmed-article:19456822pubmed:meshHeadingpubmed-meshheading:19456822...lld:pubmed
pubmed-article:19456822pubmed:meshHeadingpubmed-meshheading:19456822...lld:pubmed
pubmed-article:19456822pubmed:meshHeadingpubmed-meshheading:19456822...lld:pubmed
pubmed-article:19456822pubmed:meshHeadingpubmed-meshheading:19456822...lld:pubmed
pubmed-article:19456822pubmed:meshHeadingpubmed-meshheading:19456822...lld:pubmed
pubmed-article:19456822pubmed:meshHeadingpubmed-meshheading:19456822...lld:pubmed
pubmed-article:19456822pubmed:meshHeadingpubmed-meshheading:19456822...lld:pubmed
pubmed-article:19456822pubmed:meshHeadingpubmed-meshheading:19456822...lld:pubmed
pubmed-article:19456822pubmed:meshHeadingpubmed-meshheading:19456822...lld:pubmed
pubmed-article:19456822pubmed:meshHeadingpubmed-meshheading:19456822...lld:pubmed
pubmed-article:19456822pubmed:meshHeadingpubmed-meshheading:19456822...lld:pubmed
pubmed-article:19456822pubmed:meshHeadingpubmed-meshheading:19456822...lld:pubmed
pubmed-article:19456822pubmed:meshHeadingpubmed-meshheading:19456822...lld:pubmed
pubmed-article:19456822pubmed:year2010lld:pubmed
pubmed-article:19456822pubmed:articleTitleHepatitis B virus subgenotype C2 is the most prevalent subgenotype in northeast China.lld:pubmed
pubmed-article:19456822pubmed:affiliationResearch Centre of the Second Affiliated Hospital, Harbin Medical University, China.lld:pubmed
pubmed-article:19456822pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19456822pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19456822lld:pubmed